AAAAAA

   
Results: 1-11 |
Results: 11
LEUKEMOID MONOCYTOSIS IN M4 AML FOLLOWING CHEMOTHERAPY AND G-CSF
Authors: RANAGHAN L DRAKE M HUMPHREYS MW MORRIS TCM
Citation: L. Ranaghan et al., LEUKEMOID MONOCYTOSIS IN M4 AML FOLLOWING CHEMOTHERAPY AND G-CSF, Clinical and laboratory haematology, 20(1), 1998, pp. 49-51
IMMUNOGLOBULIN IMMUNOSTAINING SHOULD BE INTEGRAL-PART OF THE INVESTIGATION PARAPROTEINEMIAS
Authors: KETTLE P CONNOLLY N RANAGHAN L MARKEY G MORRIS TCM
Citation: P. Kettle et al., IMMUNOGLOBULIN IMMUNOSTAINING SHOULD BE INTEGRAL-PART OF THE INVESTIGATION PARAPROTEINEMIAS, British Journal of Haematology, 101, 1998, pp. 104-104
ANALYSIS OF THE EFFECT OF PRIOR THERAPY ON PROGENITOR-CELL YIELD - USE OF A CHEMOTHERAPY SCORING SYSTEM. (VOL 98, PG 745, 1997)
Authors: DRAKE M RANAGHAN L MORRIS TCM NOLAN L DESAI ZR IRVINE AE JORDAN A MAGILL K PRICE S
Citation: M. Drake et al., ANALYSIS OF THE EFFECT OF PRIOR THERAPY ON PROGENITOR-CELL YIELD - USE OF A CHEMOTHERAPY SCORING SYSTEM. (VOL 98, PG 745, 1997), British Journal of Haematology, 99(2), 1997, pp. 474-474
ANALYSIS OF THE EFFECT OF PRIOR THERAPY ON PROGENITOR-CELL YIELD - USE OF A CHEMOTHERAPY SCORING SYSTEM
Authors: DRAKE M RANAGHAN L MORRIS TCM NOLAN L DESAI ZR IRVINE AE JORDAN A MAGILL K PRICE S
Citation: M. Drake et al., ANALYSIS OF THE EFFECT OF PRIOR THERAPY ON PROGENITOR-CELL YIELD - USE OF A CHEMOTHERAPY SCORING SYSTEM, British Journal of Haematology, 98(3), 1997, pp. 745-749
SERUM CYTOKINE AND CRP LEVELS PRE-PERIPHERAL AND POST-PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION
Authors: MAGILL MK IRVINE AE DRAKE M LLOYD F RANAGHAN L DESAI ZR MORRIS TCM
Citation: Mk. Magill et al., SERUM CYTOKINE AND CRP LEVELS PRE-PERIPHERAL AND POST-PERIPHERAL BLOOD STEM-CELL TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 86-86
PERIPHERAL-BLOOD STEM-CELL YIELD IS AFFECTED BY PRIOR CHEMOTHERAPY
Authors: DRAKE M NOLAN L RANAGHAN L DESAI ZR JORDAN A PRICE S IRVINE AE MORRIS TCM
Citation: M. Drake et al., PERIPHERAL-BLOOD STEM-CELL YIELD IS AFFECTED BY PRIOR CHEMOTHERAPY, British Journal of Haematology, 93, 1996, pp. 172-172
CD34 DOSE INFLUENCES TIME TO HEMATOLOGICAL RECOVERY AND SUPPORTIVE CARE REQUIREMENTS IN AUTOLOGOUS PBSC TRANSPLANTATION
Authors: RANAGHAN L NOLAN L DRAKE M DESAI ZR JORDAN A MAGILL K MORRIS TCM
Citation: L. Ranaghan et al., CD34 DOSE INFLUENCES TIME TO HEMATOLOGICAL RECOVERY AND SUPPORTIVE CARE REQUIREMENTS IN AUTOLOGOUS PBSC TRANSPLANTATION, British Journal of Haematology, 93, 1996, pp. 173-173
BONE-MARROW NECROSIS - REPLY
Authors: MORRIS TCM MARKEY GM RANAGHAN L
Citation: Tcm. Morris et al., BONE-MARROW NECROSIS - REPLY, American journal of hematology, 50(1), 1995, pp. 66-66
DRUG-INDUCED NEUTROPENIA DUE TO DIRECT EFFECTS ON CFU-C - 10 YEARS OFCULTURE EXPERIENCE
Authors: IRVINE AE FRENCH A DALY A RANAGHAN L MORRIS TCM
Citation: Ae. Irvine et al., DRUG-INDUCED NEUTROPENIA DUE TO DIRECT EFFECTS ON CFU-C - 10 YEARS OFCULTURE EXPERIENCE, European journal of haematology, 52(1), 1994, pp. 21-27
BONE-MARROW NECROSIS
Authors: RANAGHAN L MORRIS TCM DESAI ZR MARKEY GM
Citation: L. Ranaghan et al., BONE-MARROW NECROSIS, American journal of hematology, 47(3), 1994, pp. 225-228
MYELOMA - RESULTS OF TREATMENT 1986-1990
Authors: KETTLE P RANAGHAN L MARKEY GM ROBERTSON JH DESAI ZR BHARUCHA C MORRIS TCM
Citation: P. Kettle et al., MYELOMA - RESULTS OF TREATMENT 1986-1990, Ulster medical journal, 62(1), 1993, pp. 11-20
Risultati: 1-11 |